← 產業報告目錄
Pharma Parenteral Packaging Market – By Drug Type (Small Molecules, Biologics, Vaccines, Biosimilars, & Others), By Product Type (Bottles, Ampoules, Vials, Prefilled syringes, Cartridges, & Others), By Material (Glass, Polymer, PVC, Others), By Packaging Type (Small Volume Parenteral, Large Volume Parenteral), By Region, And By Segment Forecasts, 2025-2034
出版商 InsightAce Analytic產業別 Other出版日期 2026-03-21頁數 180報告編號 INSIGHTACE-065976a751
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
報告摘要
In 2024, the Pharma Parenteral Packaging Market – By Drug Type (Small Molecules worldwide was assessed at USD 13.6 Billion. Analysts project it will accelerate to USD 21.5 Billion by 2034, at a CAGR of 4.8% spanning 2025 to 2034.
Pharma Parenteral Packaging – By Drug Type (Small Molecules covers reshaping how industrial entities approach this space.
Growth is propelled by a convergence of factors: rising awareness among end users, continuous product innovation, and the growing emphasis on efficiency and sustainability within the industrial sector.
From a segmentation standpoint, the market is categorized across multiple dimensions including product type, application, end-user, and geography, each exhibiting distinct growth patterns and opportunities.
Geographically, North America maintains a leading position owing to advanced infrastructure, high R&D expenditure, and a well-established regulatory environment. Meanwhile, Asia-Pacific is emerging as the fastest-growing region, propelled by rapid industrialization and expanding end-user bases.
The competitive arena features a mix of established conglomerates and agile innovators, each vying for market position through strategic acquisitions, product launches, and capacity expansion.
This comprehensive research study delivers granular insights into market sizing, trend analysis, competitive benchmarking, and forward-looking projections to support strategic decision-making for industry participants and investors.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Pharma Parenteral Packaging Market Snapshot
Chapter 4. Global Pharma Parenteral Packaging Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: by Product Type Estimates & Trend Analysis
5.1. by Product Type & Market Share, 2024 & 2034
5.2. Market Size (Value (US$ Mn) & Volume (Tons)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Product Type:
5.2.1. Bottles
5.2.2. Ampoules
5.2.3. Vials
5.2.4. Prefilled syringes
5.2.5. Cartridges
5.2.6. Others
Chapter 6. Market Segmentation 2: by Drug Type Estimates & Trend Analysis
6.1. by Drug Type & Market Share, 2024 & 2034
6.2. Market Size (Value (US$ Mn) & Volume (Tons)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Drug Type:
6.2.1. Small Molecules
6.2.2. Biologics
6.2.3. Vaccines
6.2.4. Biosimilars
6.2.5. Others
Chapter 7. Market Segmentation 3: by Material Estimates & Trend Analysis
7.1. by Material & Market Share, 2024 & 2034
7.2. Market Size (Value (US$ Mn) & Volume (Tons)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Material:
7.2.1. Glass
7.2.2. Polymer
7.2.3. PVC
7.2.4. Others
Chapter 8. Market Segmentation 4: by Packaging Type Estimates & Trend Analysis
8.1. by Packaging Type & Market Share, 2024 & 2034
8.2. Market Size (Value (US$ Mn) & Volume (Tons)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Packaging Type:
8.2.1. Small Volume Parenteral
8.2.2. Large Volume Parenteral
Chapter 9. Pharma Parenteral Packaging Market Segmentation 5: Regional Estimates & Trend Analysis
9.1. North America
9.1.1. North America Pharma Parenteral Packaging Market Revenue (US$ Million) & Volume (Tons) Estimates and Forecasts by Product Type, 2021-2034
9.1.2. North America Pharma Parenteral Packaging Market Revenue (US$ Million) & Volume (Tons) Estimates and Forecasts by Drug Type, 2021-2034
9.1.3. North America Pharma Parenteral Packaging Market Revenue (US$ Million) & Volume (Tons) Estimates and Forecasts by Material, 2021-2034
9.1.4. North America Pharma Parenteral Packaging Market Revenue (US$ Million) & Volume (Tons) Estimates and Forecasts by Packaging Type, 2021-2034
9.1.5. North America Pharma Parenteral Packaging Market Revenue (US$ Million) & Volume (Tons) Estimates and Forecasts by country, 2021-2034
9.2. Europe
9.2.1. Europe Pharma Parenteral Packaging Market Revenue (US$ Million) & Volume (Tons) Estimates and Forecasts by Product Type, 2021-2034
9.2.2. Europe Pharma Parenteral Packaging Market Revenue (US$ Million) & Volume (Tons) Estimates and Forecasts by Drug Type, 2021-2034
9.2.3. Europe Pharma Parenteral Packaging Market Revenue (US$ Million) & Volume (Tons) Estimates and Forecasts by Material, 2021-2034
9.2.4. Europe Pharma Parenteral Packaging Market Revenue (US$ Million) & Volume (Tons) Estimates and Forecasts by Packaging Type, 2021-2034
9.2.5. Europe Pharma Parenteral Packaging Market Revenue (US$ Million) & Volume (Tons) Estimates and Forecasts by country, 2021-2034
9.3. Asia Pacific
9.3.1. Asia Pacific Pharma Parenteral Packaging Market Revenue (US$ Million) & Volume (Tons) Estimates and Forecasts by Product Type, 2021-2034
9.3.2. Asia Pacific Pharma Parenteral Packaging Market Revenue (US$ Million) & Volume (Tons) Estimates and Forecasts by Drug Type, 2021-2034
9.3.3. Asia-Pacific Pharma Parenteral Packaging Market Revenue (US$ Million) & Volume (Tons) Estimates and Forecasts by Material, 2021-2034
9.3.4. Asia Pacific Pharma Parenteral Packaging Market Revenue (US$ Million) & Volume (Tons) Estimates and Forecasts by Packaging Type, 2021-2034
9.3.5. Asia Pacific Pharma Parenteral Packaging Market Revenue (US$ Million) & Volume (Tons) Estimates and Forecasts by country, 2021-2034
9.4. Latin America
9.4.1. Latin America Pharma Parenteral Packaging Market Revenue (US$ Million) & Volume (Tons) Estimates and Forecasts by Product Type, 2021-2034
9.4.2. Latin America Pharma Parenteral Packaging Market Revenue (US$ Million) & Volume (Tons) Estimates and Forecasts by Drug Type, 2021-2034
9.4.3. Latin America Pharma Parenteral Packaging Market Revenue (US$ Million) & Volume (Tons) Estimates and Forecasts by Material, 2021-2034
9.4.4. Latin America Pharma Parenteral Packaging Market Revenue (US$ Million) & Volume (Tons) Estimates and Forecasts by Packaging Type, 2021-2034
9.4.5. Latin America Pharma Parenteral Packaging Market Revenue (US$ Million) & Volume (Tons) Estimates and Forecasts by country, 2021-2034
9.5. Middle East & Africa
9.5.1. Middle East & Africa Pharma Parenteral Packaging Market Revenue (US$ Million) & Volume (Tons) Estimates and Forecasts by Product Type, 2021-2034
9.5.2. Middle East & Africa Pharma Parenteral Packaging Market Revenue (US$ Million) & Volume (Tons) Estimates and Forecasts by Drug Type, 2021-2034
9.5.3. Middle East & Africa Pharma Parenteral Packaging Market Revenue (US$ Million) & Volume (Tons) Estimates and Forecasts by Material, 2021-2034
9.5.4. Middle East & Africa Pharma Parenteral Packaging Market Revenue (US$ Million) & Volume (Tons) Estimates and Forecasts by Packaging Type, 2021-2034
9.5.5. Middle East & Africa Pharma Parenteral Packaging Market Revenue (US$ Million) & Volume (Tons) Estimates and Forecasts by country, 2021-2034
Chapter 10. Competitive Landscape
10.1. Major Mergers and Acquisitions/Strategic Alliances
10.2. Company Profiles
10.2.1 Adelphi Healthcare Packaging
10.2.2 Akorn, Inc.
10.2.3 Alcami Corporation, Inc.
10.2.4 Ardena Holding NV
10.2.5 Baxter International Inc.
10.2.6 Becton, Dickinson and Company
10.2.7 Berkshire Sterile Manufacturing
10.2.8 Berry Global Inc.
10.2.9 Catalent Inc.
10.2.10 Gerresheimer AG.
10.2.11 Nipro Corporation
10.2.12 PCI Pharma Services
10.2.13 Schott AG
10.2.14 SGD Pharma
10.2.15 SiO2 Materials Science.
10.2.16 Stevanato Group S.p.A
10.2.17 Terumo Corporation
10.2.18 UDG Healthcare Plc.
10.2.19 West Pharmaceutical Services, Inc.
10.2.20 Ypsomed Holding AG
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們